mhurhangee/ep-ind-claims huggingface dataset:
Method for the preparation of highly pure iridium chloride hydrate, comprising the steps of: Providing at least one material selected from the group consisting of solid H 2 [IrCl 6] hydrate, aqueous at least 1 wt.% H 2 [IrCl 6] solution, and solid IrCl 4 hydrate; adding, to the at least one material provided in step, at least one monohydroxy compound selected from the group consisting of methoxy ethanol, ethoxy ethanol, methoxy propanol, methanol, ethanol, n-propanol, iso-propanol, 1-butanol, 2-butanol, and 2-methyl-1-propanol at a molar ratio of Ir: monohydroxy compound = 1: 0.6 to 1,000, and allowing this to react in a temperature range of 20 to 120°C, followed by removing volatile components from the reaction mixture thus formed, whereby the term "highly pure iridium chloride hydrate" shall denote a solid iridium chloride hydrate of formula IrCl 3 · x H 2 O · y HCl whereby x = 1.5 to 5 and y = 0 to 1, and whereby the iridium contained therein is ≥ 99.9% Ir and ≤ 0.1% Ir. Providing at least one material selected from the group consisting of solid H 2 [IrCl 6] hydrate, aqueous at least 1 wt.% H 2 [IrCl 6] solution, and solid IrCl 4 hydrate; adding, to the at least one material provided in step, at least one monohydroxy compound selected from the group consisting of methoxy ethanol, ethoxy ethanol, methoxy propanol, methanol, ethanol, n-propanol, iso-propanol, 1-butanol, 2-butanol, and 2-methyl-1-propanol at a molar ratio of Ir: monohydroxy compound = 1: 0.6 to 1,000, and allowing this to react in a temperature range of 20 to 120°C, followed by removing volatile components from the reaction mixture thus formed, whereby the term "highly pure iridium chloride hydrate" shall denote a solid iridium chloride hydrate of formula IrCl 3 · x H 2 O · y HCl whereby x = 1.5 to 5 and y = 0 to 1, and whereby the iridium contained therein is ≥ 99.9% Ir and ≤ 0.1% Ir.
Sealing ring for sealing a sealing gap arranged between two machine elements (32, 36), the sealing ring comprising an elastically deformable polymer material and a support ring which is form-fittingly embedded in the polymer material at least in part, the support ring being designed as a 3D printed part having an at least partially multilayered structure of its material, and the material of the support ring having a greater modulus of elasticity than the polymer material, characterized in that the support ring can be elastically widened in a radial direction with respect to the central axis of the sealing ring and has dimensionally stable first ring segments which are hingedly connected to one another in the circumferential direction of the sealing ring.
A device for expanding tissue comprising: an elongate shaft; at least one fluid delivery tube (121a, 121b, 121n) comprising a proximal end, a distal end and a lumen therebetween, wherein the elongate shaft has a distal end that surrounds the at least one fluid delivery tube; at least two hollow fluid delivery needles (141a, 141b) in fluid communication with the at least one fluid delivery tube lumen; and an expandable support having a recess constructed and arranged to slidingly receive a said hollow fluid delivery needle (141, 141b); wherein the at least two hollow fluid delivery needles (141a, 141b)-are constructed and arranged to deliver fluid into luminal wall tissue. an elongate shaft; at least one fluid delivery tube (121a, 121b, 121n) comprising a proximal end, a distal end and a lumen therebetween, wherein the elongate shaft has a distal end that surrounds the at least one fluid delivery tube; at least two hollow fluid delivery needles (141a, 141b) in fluid communication with the at least one fluid delivery tube lumen; and an expandable support having a recess constructed and arranged to slidingly receive a said hollow fluid delivery needle (141, 141b); wherein the at least two hollow fluid delivery needles (141a, 141b)-are constructed and arranged to deliver fluid into luminal wall tissue.
An apparatus for emptying bags, comprising a gripping unit for picking up bags, and a bag slitting and emptying device to which the bags are brought by the gripping unit and at which the bags are emptied, characterized in that • said gripping unit comprises a gripper having a plurality of pointed gripping elements (44, 46, 62, 63, 72, 74, 76) arranged in at least two arrays (62, 63; 62B, 63B; 72, 74), such that the pointed gripping elements of one array point in the opposite direction to the other array, for gripping at least one of said bags, said pointed gripping elements having a first end connected to said gripper and a second tipped free end, and being moveable between a first position in which said pointed gripping elements are retracted and a second position in which said pointed gripping elements are extended, and • the bag slitting and emptying device, comprises: ∘ at least two parallel rotary blades for slitting said at least one bag,and ∘ at least two rods aligned in a row respectively with said rotary blades, being shakeable relative to said at least one slitted bag. • said gripping unit comprises a gripper having a plurality of pointed gripping elements (44, 46, 62, 63, 72, 74, 76) arranged in at least two arrays (62, 63; 62B, 63B; 72, 74), such that the pointed gripping elements of one array point in the opposite direction to the other array, for gripping at least one of said bags, said pointed gripping elements having a first end connected to said gripper and a second tipped free end, and being moveable between a first position in which said pointed gripping elements are retracted and a second position in which said pointed gripping elements are extended, and • the bag slitting and emptying device, comprises: ∘ at least two parallel rotary blades for slitting said at least one bag,and ∘ at least two rods aligned in a row respectively with said rotary blades, being shakeable relative to said at least one slitted bag. ∘ at least two parallel rotary blades for slitting said at least one bag,and ∘ at least two rods aligned in a row respectively with said rotary blades, being shakeable relative to said at least one slitted bag.
Apparatus for analysing a pharmaceutical dosage form, comprising: a rotation stage having a rotation stage surface arranged to receive a dosage form which has opposing major faces separated by an edge face; a gripper arranged to grasp the dosage form; a Raman analysis station having a test location and arranged to detect Raman spectral features in probe light scattered within the dosage form when positioned at the test location; a controller arranged to control rotation of the rotation stage so as to rotate the dosage form when on the stage surface to a preferred alignment, to control the gripper to grasp the dosage form in the preferred alignment, and to control the gripper to carry the grasped dosage form to the test location for Raman analysis; and a machine vision system arranged to detect alignment of the dosage form when on the rotation stage surface, and to pass the detected alignment of the dosage form to the controller for controlling rotation of the rotation stage to rotate the dosage form to the preferred alignment, the controller being further arranged to control the gripper to rotate the dosage form and place the dosage form on edge onto the rotation stage so as to present the edge face of the dosage form to the machine vision system, the machine vision system being further arranged to determine a thickness of the dosage form from the presented edge face. a rotation stage having a rotation stage surface arranged to receive a dosage form which has opposing major faces separated by an edge face; a gripper arranged to grasp the dosage form; a Raman analysis station having a test location and arranged to detect Raman spectral features in probe light scattered within the dosage form when positioned at the test location; a controller arranged to control rotation of the rotation stage so as to rotate the dosage form when on the stage surface to a preferred alignment, to control the gripper to grasp the dosage form in the preferred alignment, and to control the gripper to carry the grasped dosage form to the test location for Raman analysis; and a machine vision system arranged to detect alignment of the dosage form when on the rotation stage surface, and to pass the detected alignment of the dosage form to the controller for controlling rotation of the rotation stage to rotate the dosage form to the preferred alignment, the controller being further arranged to control the gripper to rotate the dosage form and place the dosage form on edge onto the rotation stage so as to present the edge face of the dosage form to the machine vision system, the machine vision system being further arranged to determine a thickness of the dosage form from the presented edge face.
An impeller associated with a compressor of a gas turbine engine, comprising: a plurality of impeller blades, each impeller blade of the plurality of impeller blades having a leading edge, a trailing edge opposite the leading edge in a streamwise direction, each impeller blade of the plurality of impeller blades extending in a spanwise direction from a hub at 0% span to a tip at 100% span, each impeller blade of the plurality of impeller blades having a plurality of mean camber lines that each extend from the leading edge to the trailing edge at a respective spanwise location, with the leading edge including a partially swept leading edge surface defined between 70% span to 100% span that extends in the streamwise direction between 3% to 15% of the tip of the impeller blade, characterized in that at 70% span a point at the leading edge including the partially swept leading edge surface is at 0% of a mean camber line in the streamwise direction, and wherein at 80% of the span downstream of the leading edge, the partially swept leading edge surface is defined at between 1% to 7% of a mean camber line at 80% span.
A method for controlling a cascade-fed asynchronous generator in connection with a voltage dip of a network fed by the generator, wherein a frequency converter is connected between the rotor of the asynchronous generator and the network, wherein the frequency converter consists of two controllable bridges: a network bridge and a load bridge, the method comprising measuring the magnitude of the voltage in the network; calculating, on the basis of the voltage in the network, a base value for reactive current to be fed to the network; generating reactive current in the network by the generator by exciting the rotor with the load bridge; measuring the stator current; determining the actual value of the reactive current in the network; calculating the difference between the base value and the actual value of the reactive current; characterized by giving the calculated difference to the network bridge of the frequency converter to serve as an instruction in reactive current; and generating reactive current in the network by the network bridge of the frequency converter in accordance with the instruction in reactive current.
Use of a monoclonal antibody (mAb) that binds to FGFR2 comprising a mature light chain variable region comprising CDR1, CDR2, and CDR3 respectively defined by residues 24-34, 50-56, and 89-97 of SEQ ID NO:1 and a mature heavy chain variable region comprising CDR1, CDR2, and CDR3 respectively defined by residues 31-35, 50-66 and 99-103 of SEQ ID NO:4 to measure the level of fibroblast growth factor receptor 2 in a tumor biopsy specimen.
A method for preparing amplified RNA (aRNA) to be used for gene expression analysis of an RNA sample wherein the RNA sample is extracted from a fixed tissue or cell(s)and the method comprises an RNA amplification step which comprises a reverse transcription step and an in vitro transcription step, wherein the ratio of 5-(3-aminoallyl)uridine 5'-triphosphate (AA-UTP) contained in a nucleotide reagent used in said in vitro transcription step is not less than 5 mol% and less than 25 mol% with respect to total of uridine 5'-triphosphate and 5-(3-aminoallyl)uridine 5'-triphophate (AA-UTP) and wherein the number of times of the RNA amplification step to be carried out is one.
A device for retaining hemodialysis circuit components, the device comprising: a body having a first portion and a second portion adjacent to the first portion, the first portion having a plurality of recesses (212,218,222,230,235,241,243) configured to retain tubes and a first aperture that intersects at least one of the recesses (212,218,222,230,235,241,243), the second portion having a first slot along a top edge of the second portion and a second slot along a side edge of the second portion, the first and second slots (312,314) being arranged to allow the body to capture a dialyzer. a body having a first portion and a second portion adjacent to the first portion, the first portion having a plurality of recesses (212,218,222,230,235,241,243) configured to retain tubes and a first aperture that intersects at least one of the recesses (212,218,222,230,235,241,243), the second portion having a first slot along a top edge of the second portion and a second slot along a side edge of the second portion, the first and second slots (312,314) being arranged to allow the body to capture a dialyzer.
A method for cooling a furnace electrode made of graphite, comprising: mixing a surfactant comprising an alkylphenol and an oxirane polymer with water to form a cooling liquid, whereby the surfactant is present in the cooling liquid in an amount in a range of from 10 mg/l to 5,000 mg/l, and spraying at least a surface of the furnace electrode disposed adjacent a furnace with the cooling liquid, thereby cooling the furnace electrode. mixing a surfactant comprising an alkylphenol and an oxirane polymer with water to form a cooling liquid, whereby the surfactant is present in the cooling liquid in an amount in a range of from 10 mg/l to 5,000 mg/l, and spraying at least a surface of the furnace electrode disposed adjacent a furnace with the cooling liquid, thereby cooling the furnace electrode.
A preservative free bimatoprost and timolol composition for use in lowering intraocular pressure in a patient comprising the following formulation: 0.03% w/v bimatoprost; 0.5% timolol; 0.268% w/v sodium phosphate dibasic heptahydrate; 0.014% citric acid monohydrate; 0.68% sodium chloride; water and having a pH of 7.3.
A control method of a laundry machine comprising: a water supplying step configured to open a water supply valve to supply water to a tub; a laundry wetting step to wet laundry loaded into a drum by the supplied water; and a circulating step configured to circulate water inside the tub to re-supply the water to the tub, the circulating step being implemented in a heating step, wherein in the heating step, a water temperature is steadily increased by heating the water using a heater, while a circulation pump for circulating the water is repeatedly turned on/off at a predetermined interval. a water supplying step configured to open a water supply valve to supply water to a tub; a laundry wetting step to wet laundry loaded into a drum by the supplied water; and a circulating step configured to circulate water inside the tub to re-supply the water to the tub, the circulating step being implemented in a heating step, wherein in the heating step, a water temperature is steadily increased by heating the water using a heater, while a circulation pump for circulating the water is repeatedly turned on/off at a predetermined interval.
A method for producing sepiapterin represented by formula: or a salt thereof, comprising subjecting lactoylpterin represented by formula: or a salt thereof to a catalytic reduction under basic conditions.
A tensioning frame for posters made of a flexible, printable carrier material, the frame consisting of a circumferential framework made of essentially rigid frame profiles and of fastening devices for fixing the carrier material formed at least on the upper and lower edges of said tensioning frame, wherein at least in the upper region of the tensioning frame, a tensioning yoke for holding the upper edge of the carrier material is provided and the tensioning yoke is mounted on the upper frame profile in such a manner as to be pivotable about a horizontal axis and may be pivoted and locked with respect to the upper frame profile by means of an actuatable tensioning member, characterised in that the tensioning yoke has two lever arms, i.e. a support arm and a tensioning arm, in that the carrier material is attachable to the support arm, in that the tensioning member acts on the tensioning arm in such a manner that the tensioning yoke may be pivoted and locked with respect to the upper frame profile, and in that the support arm of the tensioning yoke is supported with respect to the upper frame profile via a tensioning spring, wherein the support arm is pressed upwardly and thus exerts pre-tension on the carrier material.
A driver brake valve for a compressed air brake system of a commercial vehicle, wherein the driver brake valve can be actuated by a brake pedal and is provided for outputting an analog driver brake pressure and an electrical sensor useful signal depending on the actuation of the brake pedal, wherein the driver brake valve has a compressed air input for connection to a system pressure, a compressed air output for connection of a brake control line, and a sensor for determining an actuation of the brake pedal, the driver brake valve has a characteristic curve memory device with stored characteristic curve data and a determination device, the sensor is configured to generate an actuation signal depending on the actuation of the brake pedal, and the determination device is configured to generate the sensor useful signal from the actuation signal depending on the characteristic curve data stored in the characteristic curve memory, characterized in that the characteristic curve data (KL, P-SW) stored in the characteristic curve memory are formed by calibrating the driver brake valve and measuring the output driver brake pressure. wherein the driver brake valve can be actuated by a brake pedal and is provided for outputting an analog driver brake pressure and an electrical sensor useful signal depending on the actuation of the brake pedal, wherein the driver brake valve has a compressed air input for connection to a system pressure, a compressed air output for connection of a brake control line, and a sensor for determining an actuation of the brake pedal, the driver brake valve has a characteristic curve memory device with stored characteristic curve data and a determination device, the sensor is configured to generate an actuation signal depending on the actuation of the brake pedal, and the determination device is configured to generate the sensor useful signal from the actuation signal depending on the characteristic curve data stored in the characteristic curve memory, characterized in that the characteristic curve data (KL, P-SW) stored in the characteristic curve memory are formed by calibrating the driver brake valve and measuring the output driver brake pressure.
An electromagnetic brake comprising: an electromagnet arranged about a central axis; a slide movable with respect to the electromagnet in a slide actuation direction upon actuation of the electromagnet, and an air gap provided between the electromagnet and the slide through which a magnetic field passes when the electromagnet is actuated, wherein the slide is arranged radially inside or outside of the electromagnet with respect to the central axis, wherein the electromagnet comprises a coil wound about the central axis and adapted to generate the magnetic field upon excitation, characterized by magnetic field adaptation means (6, 7) for adapting the magnetic field so as to generate a magnetic force acting on the slide in the slide actuation direction, wherein the magnetic field adaptation means (6, 7) comprises at least one electromagnet projection projecting from the electromagnet into the air gap, and at least one slide projection projecting from the slide into the air gap, wherein the electromagnet projection and the slide projection are offset from each other in the slide actuation direction in the state of the electromagnet not being actuated. an electromagnet arranged about a central axis; a slide movable with respect to the electromagnet in a slide actuation direction upon actuation of the electromagnet, and an air gap provided between the electromagnet and the slide through which a magnetic field passes when the electromagnet is actuated, wherein the electromagnet comprises a coil wound about the central axis and adapted to generate the magnetic field upon excitation, characterized by magnetic field adaptation means (6, 7) for adapting the magnetic field so as to generate a magnetic force acting on the slide in the slide actuation direction, wherein the magnetic field adaptation means (6, 7) comprises at least one electromagnet projection projecting from the electromagnet into the air gap, and at least one slide projection projecting from the slide into the air gap, wherein at least one electromagnet projection projecting from the electromagnet into the air gap, and at least one slide projection projecting from the slide into the air gap, wherein the electromagnet projection and the slide projection are offset from each other in the slide actuation direction in the state of the electromagnet not being actuated.
An aortic occlusion device, comprising: a radially expandable and collapsible proximal end portion and a radially expandable and collapsible distal end portion, the proximal and distal end portions (602, 604) configured to radially expand within an aorta to secure the device within the aorta, wherein the distal end portion comprises a liner configured to block a flow of blood through the distal end portion; a catheter (606, 608) extending axially between the distal end portion and the proximal end portion; a porous covering positioned around the catheter (606, 608) and between the proximal end portion and the distal end portion; and a one-way valve positioned at or adjacent the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart and allowing antegrade blood flow into the distal end portion and through the device; characterized in that the proximal end portion and the distal end portion each comprise radially expandable and collapsible frames (610, 612); the frame of the distal end portion comprises a conical portion and a cylindrical portion, and the one-way valve is positioned between the conical portion of the distal end portion and the proximal end portion, and is secured around and retained on the catheter. a radially expandable and collapsible proximal end portion and a radially expandable and collapsible distal end portion, the proximal and distal end portions (602, 604) configured to radially expand within an aorta to secure the device within the aorta, wherein the distal end portion comprises a liner configured to block a flow of blood through the distal end portion; a catheter (606, 608) extending axially between the distal end portion and the proximal end portion; a porous covering positioned around the catheter (606, 608) and between the proximal end portion and the distal end portion; and a one-way valve positioned at or adjacent the distal end portion of the device and configured to restrict retrograde blood flow through the device toward the heart and allowing antegrade blood flow into the distal end portion and through the device; characterized in that the proximal end portion and the distal end portion each comprise radially expandable and collapsible frames (610, 612); the frame of the distal end portion comprises a conical portion and a cylindrical portion, and the one-way valve is positioned between the conical portion of the distal end portion and the proximal end portion, and is secured around and retained on the catheter.